Literature DB >> 1875281

The kinetics of flurbiprofen in synovial fluid.

L Aarons1.   

Abstract

Steady state plasma and synovial fluid flurbiprofen concentrations obtained from 26 rheumatoid arthritis patients receiving 100 mg of flurbiprofen b.i.d. were analyzed using the NONMEM program. Only one synovial fluid sample per patient was available. Population estimates for the plasma parameters, clearance, volume of distribution, and elimination half-life were 1.75 L hr-1, 11.9 L, and 4.8 hr, respectively, and the corresponding interindividual variances in these parameters were 29, 19 and 23%, respectively. The apparent elimination half-life from synovial fluid was 7.1 hr. After accounting for interindividual variability there was a residual variability of approximately 40% in both the plasma and synovial fluid concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875281     DOI: 10.1007/bf03036250

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

1.  Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.

Authors:  T M Chalmers; R C Glass; P C Risdall
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

Review 2.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

Review 3.  Estimating population kinetics.

Authors:  S L Beal; L B Sheiner
Journal:  Crit Rev Biomed Eng       Date:  1982

4.  Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.

Authors:  S Wanwimolruk; P M Brooks; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

5.  Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

Authors:  L Aarons; R Salisbury; M Alam-Siddiqi; L Taylor; D M Grennan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

  5 in total
  7 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Sparse data analysis.

Authors:  L Aarons
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

3.  Plasma and cerebrospinal fluid pharmacokinetics of flurbiprofen in children.

Authors:  Elina Kumpulainen; Pyry Välitalo; Merja Kokki; Marko Lehtonen; Andrew Hooker; Veli-Pekka Ranta; Hannu Kokki
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

Review 4.  Bayesian forecasting in paediatric populations.

Authors:  M M Fernández de Gatta; M J García; J M Lanao; A Domínguez-Gil
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 5.  Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective.

Authors:  E Samara; R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

6.  Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain.

Authors:  Jingru Zhang; Hong Zhang; Libo Zhao; Jian Gu; Yi Feng; Haiyan An
Journal:  J Pain Res       Date:  2018-11-30       Impact factor: 3.133

7.  Evaluation of the effects of pregabalin on chondrocyte proliferation and CHAD, HIF-1α, and COL2A1 gene expression.

Authors:  Duygu Yasar Sirin; Numan Karaarslan
Journal:  Arch Med Sci       Date:  2018-02-02       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.